Critical Reviews in Immunology
LightNews LightNews
banner
crijournal.bsky.social
Critical Reviews in Immunology
@crijournal.bsky.social
16 followers 11 following 80 posts
Cutting-edge immunology research covering autoimmune diseases, cancer immunotherapy, transplantation & more. SCIE Impact Factor: 0.8
Discover original research and state-of-the-art reviews at www.begellhouse.com/CRI
Posts Replies Media Videos
Pinned
crijournal.bsky.social
Critical Reviews in Immunology @crijournal.bsky.social · Apr 10
Welcome to #CRI on Bluesky! Your source for the latest immunology research on autoimmune diseases & cancer immunotherapy. Follow for quality research & expert insights shaping healthcare's future. #Immunology #CancerResearch #Immunotherapy #MedicalResearch
crijournal.bsky.social
Dr. Jewett's review examines PD-1's contrasting roles: block it in cancer to boost immunity, enhance it in autoimmune diseases to suppress overactive responses.

Free until March 15: dl.begellhouse.com/journals/2ff...

#PD1 #Immunotherapy
February 13, 2026 at 5:01 PM
crijournal.bsky.social
Dr. Jewett's ALS twin study reveals elevated NK cells & hyperresponsive CD8+ T cells drive motor neuron damage, pointing to new therapies.

Free until March 15: dl.begellhouse.com/journals/2ff...

#ALS #Neuroimmunology
February 11, 2026 at 8:19 PM
crijournal.bsky.social
Honoring Dr. Jewett: Processed osteoclasts effectively "supercharge" NK cells for cancer therapy with faster prep and lower costs.

Free until Feb 15: www.dl.begellhouse.com/journals/2ff...

#NKCellTherapy #CancerImmunotherapy
February 2, 2026 at 2:34 PM
crijournal.bsky.social
Honoring Dr. Anahid Jewett's legacy: This commentary examines how SARS-CoV-2 targets and depletes natural killer cells, major immune effectors that destroy virally infected cells, contributing to COVID-19 mortality and progression

Free until Feb 15: www.dl.begellhouse.com/journals/2ff...

#COVID19
January 30, 2026 at 2:46 PM
crijournal.bsky.social
Honoring Dr. Anahid Jewett's legacy: This study investigates AJ3 probiotic bacteria to regulate immune function in ALS patients. Dr. Jewett's research shows AJ3 probiotics lower IFN-γ and increase IL-10.

Free until Feb 15:
www.dl.begellhouse.com/journals/2ff...

#ALS #Probiotics
January 28, 2026 at 4:13 PM
crijournal.bsky.social
Honoring Dr. Anahid Jewett's research in NK cell immunotherapy, we present this critical report examining therapeutic strategies for pediatric brain tumors. Dr. Jewett's findings show sNK cells are promising for treating DIPG.

Free until Feb 15: www.dl.begellhouse.com/journals/2ff...

#DIPG
January 26, 2026 at 3:20 PM
crijournal.bsky.social
Honoring Dr. Anahid Jewett: Processed osteoclasts effectively expand sNK cells with advantages in cost, time, and patient availability for NK cell therapy.

Free until Feb 15: www.dl.begellhouse.com/journals/2ff...

#SuperchargedNKCells #CellTherapy
January 23, 2026 at 3:01 PM
crijournal.bsky.social
Continuing our tribute to Dr. Anahid Jewett's immunology work: Dr. Jewett and colleagues examine how NK and CD8+ T cells contribute to ALS pathogenesis, discussing targeted therapies including supercharged NK cells.

Free until Feb 15: www.dl.begellhouse.com/references/2...

#ALS #NKCells
January 21, 2026 at 4:06 PM
crijournal.bsky.social
In honor of Dr. Anahid Jewett's legacy, we're highlighting her contributions to immunology. This review explores how probiotics activate NK cells, enhance cancer therapeutics, and reverse functional impairment.

Read free until Feb 15: www.dl.begellhouse.com/journals/2ff...

#Probiotics #NKCells
January 19, 2026 at 5:10 PM
crijournal.bsky.social
This comprehensive review by Dr. Anahid Jewett and UCLA researchers demonstrates how NK cells select and differentiate cancer stem cells, leading to growth inhibition and reduced metastasis.

Free to read until Feb 15th:
dl.begellhouse.com/journals/2ff...

#NKCells #CancerImmunotherapy
January 16, 2026 at 7:10 PM
crijournal.bsky.social
Happy New Year! 🎊

As 2026 begins, we celebrate the Year of the Horse, a symbol of energy, progress, and optimism in Chinese tradition. To our scholarly community: may this year bring success, groundbreaking discoveries, and new opportunities!

#HappyNewYear #YearOfTheHorse
December 30, 2025 at 3:56 PM
crijournal.bsky.social
Supercharged NK Cells as a Promising Therapeutic Strategy to Target and Eliminate Aggressive DIPG Tumors in Pediatric Patients

dl.begellhouse.com/journals/2ff...

#DIPG #NKCellTherapy #PediatricNeuroOncology
December 30, 2025 at 3:48 PM
crijournal.bsky.social
HOTAIR Promotes Spiral Ganglion Neuron Proliferation via miR-211-5p/EYA3 Regulation

dl.begellhouse.com/journals/2ff...

#SensorineuralHearingLoss #lncRNAHOTAIR #HearingResearch
December 23, 2025 at 2:38 PM
crijournal.bsky.social
Combination Therapy of Supercharged NK Cells and ONC201 or ONC206 to Target Aggressive K27M Brain Tumors

dl.begellhouse.com/journals/2ff...

#DIPG #NKCellTherapy #PediatricBrainTumor
December 16, 2025 at 4:30 PM
crijournal.bsky.social
The Role of FGFR2 on Proliferation, Apoptosis and Glucose Metabolism of Breast Cancer Cells

dl.begellhouse.com/journals/2ff...

#BreastCancerResearch #miR598 #MolecularOncology
December 9, 2025 at 4:20 PM
crijournal.bsky.social
Your next research role awaits. The Begell House Career Center connects scientists & engineers with opportunities in academia, government, corporate R&D, and tech organizations. From grad students to senior experts. #STEMcareers

Explore → begellhouse.careerwebsite.com
December 2, 2025 at 3:07 PM
crijournal.bsky.social
🎓University of New South Wales signed a 3-year agreement for Begell Digital Portal! Students & faculty get unlimited access to 53K+ peer-reviewed articles, Heat Exchanger Design Handbook, Thermopedia & 200+ video lectures.

Access: www.begellhouse.com/begell_digit...

#EngineeringResearch #CFD #UNSW
November 26, 2025 at 3:42 PM
crijournal.bsky.social
Dual Inhibition of IRE1α and YAP Signaling as a Potential Therapy for Epithelial Ovarian Carcinoma

dl.begellhouse.com/journals/2ff...

#OvarianCancerResearch #IRE1αYAPpathway #TargetedTherapy
November 24, 2025 at 4:26 PM
crijournal.bsky.social
Retractions & ethical challenges in scientific publishing are on the rise - driven by AI tools & paper mills.

For #PublicationIntegrityWeek, learn how Begell House works with the scholarly community to uphold trust & accountability in research:
www.begellhouse.com/news/8
November 19, 2025 at 8:22 PM
crijournal.bsky.social
30+ years of trusted cancer research, microbiology & multidisciplinary studies. This #PublicationIntegrityWeek, Begell House (@begellhouse.bsky.social) highlights our research integrity work, real biomedical cases & resources for authors/editors.
begellmedical.bsky.social Begell Medical Research @begellmedical.bsky.social · Nov 18
Publication Integrity Week (Nov 17–21) highlights why ethical publishing matters more than ever. This week, we’ll spotlight our ethics policies, the safeguards we use against fraudulent research, and perspectives on handling ethical concerns.

#PublicationIntegrityWeek
November 18, 2025 at 7:25 PM
crijournal.bsky.social
Cellular Immune Response to High-Risk Human Papillomavirus Infection: A Systematic Review

dl.begellhouse.com/journals/2ff...

#HumanPapillomavirus #CervicalCancer #ImmunologyResearch
November 17, 2025 at 2:56 PM
crijournal.bsky.social
Assessing the Relationship among Tumor Size, Lymph Node Status, and ER/PR/HER2 Expression in Patients with Breast Cancer

dl.begellhouse.com/journals/2ff...

#BreastCancerResearch #LymphNodeMetastasis #BiomarkerAnalysis
November 10, 2025 at 2:49 PM
crijournal.bsky.social
🔬 Critical Reviews in Immunology Vol. 45, Issue 6 is out!

What links melanoma, Alzheimer's & bone health? Explore NK cell therapies, inflammatory signatures & more.

Read now: www.dl.begellhouse.com/journals/2ff...

#Immunology #PrecisionMedicine
November 6, 2025 at 9:47 PM
crijournal.bsky.social
Pathogenesis, Diagnosis, Treatment, and Prognosis of CD20-Positive T and NK Cell Lymphoma: A Review

dl.begellhouse.com/journals/2ff...

#CD20Expression #NKTCellLymphoma #RituximabTherapy
November 3, 2025 at 2:21 PM
crijournal.bsky.social
Assessing the Relationship among Tumor Size, Lymph Node Status, and ER/PR/HER2 Expression in Patients with Breast Cancer

www.dl.begellhouse.com/journals/2ff...

#BreastCancerResearch #LymphNodeMetastasis #PrecisionOncology
October 30, 2025 at 2:23 PM